4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene

C120H129F9N40O2Pt5 — CID 158276713

About 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene

4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene (PubChem CID 158276713) has the molecular formula C120H129F9N40O2Pt5 and a molecular weight of 3310.00 g/mol. Its IUPAC name is 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene.

Molecular Properties

• Compound Name: 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene
• PubChem CID: 158276713
• Molecular Formula: C120H129F9N40O2Pt5
• Molecular Weight: 3310.00 g/mol
• Exact Mass: 3307.93
• IUPAC Name: 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene
• SMILES: CC(C)(C)c1cc(-c2cc(C(F)(F)F)ncn2)[n-]n1.COc1cc(-c2[n-]nc3c2C2CCC3(C)C2(C)C)ncn1.COc1cc(-c2cc(C(F)(F)F)n[n-]2)ncn1.Cc1cc(-c2[n-]nc3c2C2CCC3(C)C2(C)C)ncn1.Cc1cc(-c2[n-]nc3c2CCCC3(C)C)ncn1.Cc1cc(-c2[n-]nc3c2CCCC3(C)C)ncn1.Cc1cc(-c2cc(C(C)(C)C)n[n-]2)ncn1.Cc1cc(-c2cc(C(F)(F)F)ncn2)[n-]n1.Cc1cc(-c2cc(C)n[n-]2)ncn1.Cc1cc(-c2cc(C)n[n-]2)ncn1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2]
• InChI: InChI=1S/C16H19N4O.C16H19N4.2C14H17N4.C12H12F3N4.C12H15N4.C9H6F3N4O.C9H6F3N4.2C9H9N4.5Pt/c1-15(2)9-5-6-16(15,3)14-12(9)13(19-20-14)10-7-11(21-4)18-8-17-10;1-9-7-11(18-8-17-9)13-12-10-5-6-16(4,15(10,2)3)14(12)20-19-13;2*1-9-7-11(16-8-15-9)12-10-5-4-6-14(2,3)13(10)18-17-12;1-11(2,3)9-5-8(18-19-9)7-4-10(12(13,14)15)17-6-16-7;1-8-5-9(14-7-13-8)10-6-11(16-15-10)12(2,3)4;1-17-8-3-5(13-4-14-8)6-2-7(16-15-6)9(10,11)12;1-5-2-7(16-15-5)6-3-8(9(10,11)12)14-4-13-6;2*1-6-3-8(11-5-10-6)9-4-7(2)12-13-9;;;;;/h7-9H,5-6H2,1-4H3;7-8,10H,5-6H2,1-4H3;2*7-8H,4-6H2,1-3H3;4-6H,1-3H3;5-7H,1-4H3;2-4H,1H3;2-4H,1H3;2*3-5H,1-2H3;;;;;/q10*-1;5*+2
• InChIKey: GJRRNPRYELVUBQ-UHFFFAOYSA-N
• XLogP: 20.97
• TPSA: 546.16 Ų
• H-Bond Acceptors: 32
• Rotatable Bonds: 12
• Heavy Atoms: 176
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3310.00
LogP ≤ 5	20.97
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	32

Frequently Asked Questions

What is the IUPAC name of 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene?

The IUPAC name of 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene (CID 158276713) is 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene.

What is the SMILES notation for 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene?

The canonical SMILES for 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene is CC(C)(C)c1cc(-c2cc(C(F)(F)F)ncn2)[n-]n1.COc1cc(-c2[n-]nc3c2C2CCC3(C)C2(C)C)ncn1.COc1cc(-c2cc(C(F)(F)F)n[n-]2)ncn1.Cc1cc(-c2[n-]nc3c2C2CCC3(C)C2(C)C)ncn1.Cc1cc(-c2[n-]nc3c2CCCC3(C)C)ncn1.Cc1cc(-c2[n-]nc3c2CCCC3(C)C)ncn1.Cc1cc(-c2cc(C(C)(C)C)n[n-]2)ncn1.Cc1cc(-c2cc(C(F)(F)F)ncn2)[n-]n1.Cc1cc(-c2cc(C)n[n-]2)ncn1.Cc1cc(-c2cc(C)n[n-]2)ncn1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].

What is the InChIKey of 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene?

The InChIKey is GJRRNPRYELVUBQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H19N4O.C16H19N4.2C14H17N4.C12H12F3N4.C12H15N4.C9H6F3N4O.C9H6F3N4.2C9H9N4.5Pt/c1-15(2)9-5-6-16(15,3)14-12(9)13(19-20-14)10-7-11(21-4)18-8-17-10;1-9-7-11(18-8-17-9)13-12-10-5-6-16(4,15(10,2)3)14(12)20-19-13;2*1-9-7-11(16-8-15-9)12-10-5-4-6-14(2,3)13(10)18-17-12;1-11(2,3)9-5-8(18-19-9)7-4-10(12(13,14)15)17-6-16-7;1-8-5-9(14-7-13-8)10-6-11(16-15-10)12(2,3)4;1-17-8-3-5(13-4-14-8)6-2-7(16-15-6)9(10,11)12;1-5-2-7(16-15-5)6-3-8(9(10,11)12)14-4-13-6;2*1-6-3-8(11-5-10-6)9-4-7(2)12-13-9;;;;;/h7-9H,5-6H2,1-4H3;7-8,10H,5-6H2,1-4H3;2*7-8H,4-6H2,1-3H3;4-6H,1-3H3;5-7H,1-4H3;2-4H,1H3;2-4H,1H3;2*3-5H,1-2H3;;;;;/q10*-1;5*+2.

What are the key properties of 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene?

4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene has a molecular weight of 3310.00 g/mol, XLogP of 20.97, 12 rotatable bonds, 0 hydrogen bond donors, and 32 hydrogen bond acceptors.

Where does this data come from?

All data for 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-(trifluoromethyl)pyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;bis(4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine);4-(5-methylpyrazol-2-id-3-yl)-6-(trifluoromethyl)pyrimidine;pentakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene is sourced from PubChem (CID 158276713), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).